LOGIN
FICB combined with dexmedetomidine reduces pain, inflammatory markers and improves sleep after THA
April 2020
FICB combined with dexmedetomidine reduces pain, inflammatory markers and improves sleep after THA
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Combination of post-fascia iliaca compartment block and dexmedetomidine in pain and inflammation control after total hip arthroplasty for elder patients: a randomized control study.
J Orthop Surg Res. 2020; 15: 42.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred and nineteen elderly patients with hip fractures scheduled for a total hip arthroplasty were randomized to receive a fascia iliaca compartment blockade (FICB) and dexmedetomidine (DEX), FICB only, or control for the management of pain and inflammation. Outcomes of interest included inflammatory markers, pain at rest and during motion on a Visual Analog Scale (VAS), and sleep quality as...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.